3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Genitourinary
27
Thoracic
16
Gastrointestinal
14
Gynecologic
10
Dermatologic
8
Breast
8
Tumor-Agnostic
6
Lymphoid
6
Head & Neck
5
Other solid neoplasm
4
Sarcoma
2
Other hematologic neoplasm
2
CNS
2
Plasma cell
1
Endocrine
1
Interventions
Everolimus
18
lanreotide
7
Octreotide
7
pembrolizumab
6
Sunitinib
6
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
pasireotide
3
lenvatinib
3
arginyllysine
3
Temozolomide
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
avelumab
×
NET
×
Clear all
No trials found.